If New Blood had made Dusk 2, there’d be no Iron Lung, ‘and now David Szymanski has got a movie that made $50 million’—so maybe there’s wisdom in not churning out sequels
New Blood Interactive, the publisher-developer combination known for its successful boomer shooter titles, is eschewing the traditional industry practice of milking successful franchises for maximum profit. Instead, company leadership under CEO Dave Oshry has adopted a philosophy of reinvesting revenue from hits like ULTRAKILL into entirely new creative projects.
In an interview, Oshry explains that rather than creating sequels, spinoffs, or expanding offices based on a single successful title, New Blood prefers to use profits to fund innovative new games. This approach has reportedly enabled developer David Szymanski to create Iron Lung independently, demonstrating how the strategy supports creative diversity across the publisher’s portfolio.
The article references a film project valued at $50 million, suggesting that New Blood’s investment philosophy extends beyond games into adjacent media. By prioritizing new intellectual property over sequel production, the publisher argues there is wisdom in resisting the pressure to repeatedly capitalize on proven success, allowing developers more freedom to innovate and create original experiences rather than predictable franchise extensions.